By Dr Chansavath Phetsouphanh

Conference Papers

Carroll TM; Chadwick JA; Owen RP; White MJ; Kaplinsky J; Peneva I; Frangou A; Chang J; Xie PF; Roth A; Amess B; Lou H; McCann KJ; Berridge G; Fischer R; Phetsouphanh C; Omiyale AO; Jacobs B-A; Ahern D; Lord SR; Norris-Bulpitt S; Dobbie ST; Griffiths L; Ramirez KA; Ricciardi T; Macri MJ; Ryan A; Venhaus RR; van den Eynde BJ; Karydis I; Kessler BM; Schuster-Böckler B; Middleton MR; Lu X, 2022, 'Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), LA, New Orleans, 08 April 2022 - 13 April 2022

Esposito I; Hartnell F; Swadling L; Phetsouphanh C; Brown A; Lara CD; Folgori A; Capone S; Barnes E; Klenerman P, 2018, 'Highly immunogenic virally vectored T cell vaccine against HCV are able to induce specific CD4+T cell helper responses', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S790 - S791, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)31852-X

Martin GE; Pace M; Thornhill JP; Phetsouphanh C; Hopkins E; Meyerowitz J; Nwokolo N; Fox J; Willberg C; Klenerman P; Fidler S; Frater J, 2017, 'Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page